News & Events

This symposium will present and discuss the status of developmental neurotoxicity (DNT). Some of the topics to be discussed are:

• Scientific validation of the neurosphere DNT test methods
• DNT NAMs are already being used
• Future of DNT testing: evaluation of effects induced by mixtures using NAMs

During this course researchers, engineers, clinicians and decision makers from the pharma and biotech industry are invited to learn more about advanced tissue models in drug development. You will get more acquainted with 3D organotypic tissue cultures, organoids and microengineering of the organ-on-chip system/platforms. Challenges and future perspectives for modelling human physiology and disease pathogenesis will be discussed.

During this training, participants will learn about qualifying NAMs through CDRH’s Medical Devices Development Tools program, how to perform in silico chemical characterization, and how to use available in vitro methods for assessing irritancy, biocompatibility, pyrogenicity, and thrombogenicity.

During the fourth and final session on basement membrane extracts (BMEs), previous speakers will come together to discuss the wider topic of replacing BMEs, and the 3Rs implications of the approaches discussed.

All webinars are free to attend, but registration in advance is required to obtain access.

The MPS (Microphysiological Systems) World Summit will bring together a global audience compsed of various stakeholders governmental and academic institutions, research communities, industry, policy makers, and more to create a roadmap for MPS technologies.

A series of international conferences including two virtual events in the lead-up to the hybrid event in June 2022 is being organized. This conference is the second of the series.

Register for the conference

During this workshop, participants will have the opportunity to meet with other stakeholders and discuss how to:

• Accelerate the translation of advanced in vitro models into clinical and drug development applications;
• Develop innovative products or services based on groundbreaking technologies;
• Oovercome barriers associated with the adoption of new methods and technologies in a regulated environment.

The 4^th Life-on-Chip Conference, flanders.healthTech’s flagship event, will focus on cross-over innovations in Health. Testimonials of pioneering researchers, entrepreneurs and first application movers. Keynote lectures from industry leaders and academia on personalised medicine, digital medicine, value-based efficient healthcare and disruptive health solutions. Pitches, and matchmaking, all in one condensed program.

During this 1.5 days training, skin sensitization models such as the human Cell Line Activation Test (OECD TG 442E), LuSens and/or KeratinoSens (OECD 442D) and cell-based assays representing early key events of the skin sensitization process will be put in the spotlight. These tests can be used as part of a weight-of-evidence or Defined Approach to assess Skin Sensitization.